Drug utilization study of mirabegron (Betmiga®) using real-world healthcare databases from the Netherlands, Spain, United Kingdom and Finland (Mirabegron DUS)

27/01/2017
02/07/2024
EU PAS number:
EUPAS15063
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

178-pv-002-clp-en-final-v1-02

English (1.34 MB - PDF) View document
Updated protocol

PHARMO-Study Protocol-Mirabegron DUS_v1.2

First published: 22/02/2024
English (1.39 MB - PDF) View document
Study results
Study results

178-pv-002-clgr-disc01-en-final-04

English (111.31 KB - PDF) View document
Study report
Other information